20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Gainers
- Vaxart, Inc. (NASDAQ:VXRT) shares surged 42.11 percent to close at $2.34 on Tuesday after the company initiated a Phase 1b clinical trial for its bivalent norovirus vaccine.
- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shares gained 39.64 percent to close at $3.84.
- IMAC Holdings, Inc. (NASDAQ:IMAC) shares gained 34.54 percent to close at $4.09.
- Chaparral Energy, Inc. (NYSE:CHAP) rose 26.01 percent to close at $5.62.
- The9 Limited (NASDAQ:NCTY) surged 24.88 percent to close at $2.56.
- Realm Therapeutics Plc (NASDAQ:RLM) climbed 23.1 percent to close at $4.19.
- Iterum Therapeutics plc (NASDAQ:ITRM) rose 22.34 percent to close at $6.90. Iterum Therapeutics received QIDP for oral and intravenous formulations of sulopenem in four additional indications as well as Fast Track designation.
- Blucora Inc (NASDAQ:BCOR) gained 18.75 percent to close at $33.69 after the company reported a $100 million buyback, raised its FY19 EPS and sales guidance, and announced it will acquire 1st Global for $180 million.
- Aytu Bioscience Inc (NASDAQ:AYTU) rose 18.6 percent to close at $2.04 after the company announced two recent publications highlighting summarized findings from its MY-T study.
- StoneCo Ltd. (NASDAQ:STNE) shares surged 18.41 percent to close at $40.97 after the company reported higher-than-expected Q4 EPS and sales results.
- Soliton, Inc. (NASDAQ:SOLY) gained 17.55 percent to close at $7.30. Soliton completed clinical trials for initial FDA filing for tattoo indication.
- Aravive, Inc. (NASDAQ:ARAV) surged 16.52 percent to close at $7.69. Aravive announced retrospective analysis showing increased GAS6 levels associated with chemoresistance and decreased progression free survival in ovarian cancer.
- Miragen Therapeutics, Inc. (NASDAQ:MGEN) rose 16.49 percent to close at $3.32.
- ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares gained 16.18 percent to close at $2.80.
- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) surged 14.67 percent to close at $5.57.
- Altimmune, Inc. (NASDAQ:ALT) climbed 14.64 percent to close at $3.32 after reporting 'positive' results from NasoVAX extension study'.
- Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) gained 14 percent to close at $11.40.
- Forterra, Inc. (NASDAQ:FRTA) rose 13.27 percent to close at $4.58.
- Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) rose 12.99 percent to close at $3.48. Catalyst Pharmaceuticals reported a loss of 14 cents per share compared to the loss of 6 cents per share a year ago and the 12 cents per share consensus estimate. The company reported revenues of $500,000 for the recent fourth quarter.
- Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares rose 12.9 percent to close at $12.95.
- Blink Charging Co. (NASDAQ:BLNK) shares gained 12.64 percent to close at $3.06 after the company announced a joint venture with Eunice Energy Group. The joint venture will target European markets, starting with Greece.
- Corindus Vascular Robotics, Inc. (NYSE:CVRS) shares rose 12.44 percent to close at $2.26.
- Wrap Technologies, Inc. (NASDAQ:WRTC) climbed 12.36 percent to close at $6.00.
- Tredegar Corporation (NYSE:TG) rose 12.14 percent to close at $19.03 following Q4 earnings.
- Dermira, Inc. (NASDAQ:DERM) gained 12.05 percent to close at $14.13. Dermira reported a $110 million common stock offering.
- Advanced Micro Devices, Inc. (NASDAQ:AMD) gained 12.04 percent to close at $26.00. Shares of several semiconductor companies are trading higher after NVIDIA teamed up with Amazon Web Services IoT to bring AI to millions of connected devices.
- Evolus, Inc. (NASDAQ:EOLS) rose 11.74 percent to close at $26.57, despite reporting mixed Q4 EPS, after the company secured a $100 million debt facility with Oxford Finance LLC.
- Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) climbed 11.04 percent to close at $18.50.
- Arco Platform Limited (NASDAQ:ARCE) gained 10.95 percent to close at $29.24.
- Assertio Therapeutics, Inc. (NASDAQ:ASRT) rose 10.8 percent to close at $4.72.
- Sibanye Gold Limited (NYSE:SBGL) rose 9.51 percent to close at $4.49.
- Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) gained 8.88 percent to close at $7.47 after Oppenheimer initiated an Outperform rating on the stock and announced a $28 price target.
- Ferro Corporation (NYSE:FOE) gained 8.47 percent to close at $20.49 after S&P Dow Jones Indices announced that Ferro will replace First Financial Bankshares in the S&P SmallCap 600 on Friday, March 22.
- Michaels Companies Inc (NASDAQ:MIK) rose 8.31 percent to close at $12.79 after reporting better-than-expected results for its fourth quarter.
- Syneos Health, Inc. (NASDAQ:SYNH) rose 8.25 percent to close at $51.40 after the company reported higher-than-expected Q4 EPS results. The company also issued FY19 EPS guidance on the high-end of analyst estimates.
- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) shares rose 7.18 percent to close at $28.22.
- Professional Diversity Network, Inc. (NASDAQ:IPDN) gained 7.14 percent to close at $3.00.
- SemiLEDs Corporation (NASDAQ:LEDS) gained 6.74 percent to close at $3.80.
- Tronox Ltd (NYSE:TROX) gained 5.22 percent to close at $12.70 following a media report the company will be selling its North American titanium dioxide business for $700 million.
- X Financial (NYSE:XYF) shares rose 4.7 percent to close at $6.47 following Q4 results.
- Fiat Chrysler Automobiles N.V. (NYSE:FCAU) shares rose 4 percent to close at $15.11 after the Peugeot family hinted it could be interested in acquiring Fiat as a part of PSA Group.
- NVIDIA Corporation (NASDAQ:NVDA) rose 3.9 percent to close at $175.71 after the company teamed up with Amazon Web Services IoT to bring AI to millions of connected devices.
Losers
- resTORbio, Inc. (NASDAQ:TORC) tumbled 22.87 percent to close at $6.98 after the company reported Q4 results and announced a $50 million common stock offering.
- Urovant Sciences Ltd (NASDAQ:UROV) shares dropped 20.92 percent to close at $11.00 after the company announced its Vibegron met its primary endpoints in a phase 3 trial.
- AquaBounty Technologies, Inc. (NASDAQ:AQB) dropped 20.36 percent to close at $2.2300. AquaBounty priced its 3.35 million share common stock offering at $2.25 per share.
- Phunware Inc. (NASDAQ:PHUN) shares dropped 18.63 percent to close at $41.50.
- PHI, Inc. (NASDAQ:PHII) declined 18.47 percent to close at $2.02 following Q4 results.
- Selecta Biosciences, Inc. (NASDAQ:SELB) shares declined 17.97 percent to close at $2.52.
- Emerge Energy Services LP (NYSE:EMES) fell 16.73 percent to close at $2.09.
- Liquidia Technologies, Inc. (NASDAQ:LQDA) dipped 15.45 percent to close at $15.21 after reporting a proposed 3 million share common stock offering.
- DSW Inc. (NYSE:DSW) shares dropped 12.89 percent to close at $22.09 after reporting downbeat quarterly earnings.
- Daré Bioscience, Inc. (NASDAQ:DARE) fell 12.45 percent to close at $1.80.
- Orion Group Holdings, Inc. (NYSE:ORN) shares dropped 12.26 percent to close at $3.72.
- Cool Holdings, Inc. (NASDAQ:AWSM) fell 12.1 percent to close at $3.10.
- B Communications Ltd (NASDAQ:BCOM) shares dropped 12.09 percent to close at $3.4800.
- Globus Maritime Limited (NASDAQ:GLBS) dipped 11.71 percent to close at $4.07.
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) shares declined 11.63 percent to close at $2.28.
- Pareteum Corporation (NASDAQ:TEUM) dropped 11.4 percent to close at $5.05.
- NanoString Technologies, Inc. (NASDAQ:NSTG) dipped 10.96 percent to close at $24.28 after reporting a 4.5 million share common stock offering.
- Titan Medical Inc. (NASDAQ:TMDI) fell 10.54 percent to close at $2.9950.
- Innovate Biopharmaceuticals, Inc. (NASDAQ:INNT) fell 10.48 percent to close at $2.2200 after climbing 14.9439 percent on Monday.
- Gritstone Oncology, Inc. (NASDAQ:GRTS) dropped 9.97 percent to close at $11.92.
- Bio-Path Holdings, Inc. (NASDAQ:BPTH) dipped 9.68 percent to close at $25.20.
- PFSweb, Inc. (NASDAQ:PFSW) fell 9.59 percent to close at $5.75 after reporting downbeat Q4 earnings.
- Esperion Therapeutics, Inc. (NASDAQ:ESPR) dropped 9.48 percent to close at $43.95.
- Covenant Transportation Group, Inc. (NASDAQ:CVTI) fell 8.36 percent to close at $19.61 on worse-than-expected Q1 guidance.
- Revlon Inc (NYSE:REV) declined 6.87 percent to close at $18.02 after the company reported lower-than-expected Q4 EPS and sales results.
- Del Taco Restaurants, Inc. (NASDAQ:TACO) fell 6.61 percent to close at $9.89 after the company reporter lower-than-expected Q4 EPS results. The company also issued FY19 EPS guidance below analyst estimates and FY19 sales on the low-end of analyst estimates.
- Cactus Inc (NYSE:WHD) dropped 4.9 percent to close at $35.88 after a shareholder of the company priced an 8.5 million share offering at $36.25 per share.
- Yext, Inc. (NYSE:YEXT) shares fell 4.2 percent to close at $22.04. Yext priced its 6.1 million share offering of common stock at $21.50 per share.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!